Clinical Trials
4 trialsNCT02164461 2024-05-20
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
Phase 1 Completed
NCT00365716 2015-10-07
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01379534 2015-05-20
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Novartis
Phase 2 Completed
NCT00526331 2012-01-16
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Phase 4 Completed